Table 3.
The 16 conditions of a full (2 × 2 × 2 × 2) factorial design
| Cell # | Treatment condition | OV | AR | ICT | Med |
|---|---|---|---|---|---|
| 1 | [RE+] OV + AR + ICT + Med | On | On | On | On |
| 2 | [RE+] OV + AR + ICT | On | On | On | Placebo |
| 3 | [RE+] OV + AR + Med | On | On | Sham | On |
| 4 | [RE+] OV + ICT + Med | On | Off | On | On |
| 5 | [RE+] AR + ICT + Med | Off | On | On | On |
| 6 | [RE+] OV + AR | On | On | Sham | Placebo |
| 7 | [RE+] OV + ICT | On | Off | On | Placebo |
| 8 | [RE+] OV + Med | On | Off | Sham | On |
| 9 | [RE+] AR + ICT | Off | On | On | Placebo |
| 10 | [RE+] AR + Med | Off | On | Sham | On |
| 11 | [RE+] ICT + Med | Off | Off | On | On |
| 12 | [RE+] OV | On | Off | Sham | Placebo |
| 13 | [RE+] AR | Off | On | Sham | Placebo |
| 14 | [RE+] ICT | Off | Off | On | Placebo |
| 15 | [RE+] Med | Off | Off | Sham | On |
| 16 | RE only | Off | Off | Sham | Off |
RE self-monitoring and regular eating, OV reducing overvaluation of shape and weight, AR adaptive responses to cues, ICT inhibitory control training, Med anti-depressant medication